Table 2.
Outcome | Study group (n = 56) | Control group (n = 53) | Relative risk (95% CI) | P valuea |
---|---|---|---|---|
Mode of delivery, n (%) | 0.13 | |||
Vaginal delivery | 20 (35.7) | 12 (22.6) | Reference | |
Cesarean | 36 (64.3) | 41 (77.4) | 0.83 (0.65–1.06) | |
Reason for C-section, n (%) | ||||
Repeat C-sections | 8 (17.4) | 13 (26.5) | 0.62 (0.28–1.37) | 0.22 |
Fetal distress | 8 (17.4) | 10 (20.4) | 0.80 (0.34–1.88) | 0.60 |
Maternal disease | 12 (26.1) | 13 (26.5) | 0.92 (0.46–1.85) | 0.82 |
Cephalopelvic disproportion/macrosomia | 3 (6.5) | 4 (8.2) | 0.75 (0.18–3.20) | 1.00b |
Failure to induce labor | 8 (17.4) | 3 (6.1) | 2.67 (0.74–9.55) | 0.11 |
Other | 7 (15.2) | 6 (12.3) | 1.17 (0.42–3.26) | 0.76 |
Maternal morbidity, n (%) | 0.89b | |||
No morbidity | 48 (85.7) | 44 (83) | Reference | |
PE | 7 (12.5) | 8 (15.1) | 0.86 (0.32–2.12) | |
Other | 1 (1.8) | 1 (1.9) | 0.92 (0.06–14.25) | |
Maternal admission to the intensive unit care, n (%) | 5 (9.1) | 8 (15.1) | 0.60 (0.21–1.72) | 0.33 |
aCalculated with chi-square test; bcalculated with Fisher's exact test; PE: preeclampsia.